Novocure Says Optune Pax Receives CE Mark For Treatment Of Adult Patients With Locally Advanced Pancreatic Cancer Of Exocrine Origin, Concomitant With Gem/Nab-Pac

뉴스 본문을 불러오고 있어요.

Novocure Says Optune Pax Receives CE Mark For Treatment Of Adult Patients With Locally Advanced Pancreatic Cancer Of Exocrine Origin, Concomitant With Gem/Nab-Pac | 웨이프 WAPE

Novocure Says Optune Pax Receives CE Mark For Treatment Of Adult Patients With Locally Advanced Pancreatic Cancer Of Exocrine Origin, Concomitant With Gem/Nab-Pac

기사 요약

관련 종목

댓글 —